A Randomized Controlled Pilot Trial of Azithromycin or Artesunate Added to Sulfadoxine-Pyrimethamine as Treatment for Malaria in Pregnant Women
2007

Treatment for Malaria in Pregnant Women

Sample size: 141 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kalilani Linda, Mofolo Innocent, Chaponda Marjorie, Rogerson Stephen J., Alker Alisa P., Kwiek Jesse J., Meshnick Steven R.

Primary Institution: Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, United States of America

Hypothesis

Can azithromycin or artesunate combined with sulfadoxine-pyrimethamine effectively treat malaria in pregnant women?

Conclusion

Both SP-artesunate and SP-azithromycin were found to be safe and effective for treating malaria in pregnant women.

Supporting Evidence

  • The parasite clearance time was significantly faster in the SP-artesunate group.
  • Recrudescent episodes of malaria were less frequent with SP-azithromycin and SP-artesunate compared to SP monotherapy.
  • All treatment regimens were well tolerated with minimal adverse effects.

Takeaway

This study tested new malaria treatments for pregnant women and found that two combinations worked well and were safe.

Methodology

A randomized open-label clinical trial with 141 pregnant women assigned to three treatment groups.

Potential Biases

Potential bias due to lack of blinding for participants and study nurses.

Limitations

The small sample size limited the evaluation of effects on birth outcomes and maternal health.

Participant Demographics

Pregnant women aged 15-49 with uncomplicated Plasmodium falciparum malaria.

Statistical Information

P-Value

p<0.01

Confidence Interval

95% CI 0.06 to 0.63

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0001166

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication